Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis
Authors:
- 29 April 2009
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (5) , 1255-1260
Abstract
Objective: Recent advances have led to novel identification of genetic polymorphisms that are associated with susceptibility to rheumatoid arthritis (RA). Currently, 5 loci (HLA, PTPN22, TRAF1/C5, TNFAIP3, and STAT4) have been consistently reported, whereas others have been observed less systematically. The aim of the present study was to independently replicate 3 recently described RA susceptibility loci, STAT4, IL2/IL21, and CTLA4, in a large Dutch case–control cohort, and to perform a meta‐analysis of all published studies to date and investigate the relevance of the findings in clinically well‐defined subgroups of RA patients with or without autoantibodies.Methods: The STAT4, IL2/IL21, and CTLA4 gene polymorphisms (rs7574865, rs6822844, and rs3087243, respectively) were genotyped in 877 RA patients and 866 healthy individuals. A meta‐analysis of all published studies of disease association with these polymorphisms was performed using the Mantel‐Haenszel fixed‐effects method.Results: An association of STAT4, IL2/IL21, and CTLA4 with RA was detected in Dutch patients (odds ratio [OR] 1.19 [P = 0.031], OR 0.84 [P = 0.051], and OR 0.87 [P = 0.041], respectively). Results from the meta‐analysis confirmed an association of all 3 polymorphisms with RA in Caucasians (OR 1.24 [P = 1.66 × 10−11], OR 0.78 [P = 5.6 × 10−5], and OR 0.91 [P = 1.8 × 10−3], respectively). The meta‐analysis also revealed that STAT4 predisposed to disease development equally in patients with autoantibodies and those without autoantibodies, and that CTLA4 enhanced the development of anti–citrullinated protein antibody (ACPA)–positive RA as compared with ACPA‐negative RA.Conclusion: Our results replicate and firmly establish the association of STAT4 and CTLA4 with RA and provide highly suggestive evidence for IL2/IL21 loci as a risk factor for RA. Given the strong statistical power of our meta‐analysis to confirm a true‐positive association, these findings provide considerable support for the involvement of CTLA4 in distinct subsets of RA patients.Keywords
This publication has 20 references indexed in Scilit:
- Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous populationHuman Immunology, 2008
- Association ofSTAT4with rheumatoid arthritis: A replication study in three European populationsArthritis & Rheumatism, 2008
- Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese populationArthritis & Rheumatism, 2008
- STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in ColombiansGenes & Immunity, 2008
- Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibilityHuman Molecular Genetics, 2008
- Novel Association in Chromosome 4q27 Region with Rheumatoid Arthritis and Confirmation of Type 1 Diabetes Point to a General Risk Locus for Autoimmune DiseasesThe American Journal of Human Genetics, 2007
- STAT4and the Risk of Rheumatoid Arthritis and Systemic Lupus ErythematosusNew England Journal of Medicine, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Emerging patterns of risk factor make‐up enable subclassification of rheumatoid arthritisArthritis & Rheumatism, 2007
- A review of the MHC genetics of rheumatoid arthritisGenes & Immunity, 2004